Inspire Medical Systems (INSP) Total Current Liabilities (2017 - 2026)
Inspire Medical Systems (INSP) reported Total Current Liabilities of $89.4 million for Q1 2026, up 40.88% on a YoY basis from $63.5 million in Q1 2025, and down 6.91% sequentially from $96.1 million in Q4 2025.
Inspire Medical Systems (INSP) Total Current Liabilities (2017 - 2026) Analysis & Trends
Inspire Medical Systems (INSP) has 10 years of Total Current Liabilities data on file, last reported at $89.4 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 40.88% year-over-year to $89.4 million; the trailing twelve-month figure through Mar 2026 stood at $89.4 million (up 40.88% YoY), and the FY2025 full-year result was $96.1 million, up 8.54% from the prior year.
- Total Current Liabilities retreated to $89.4 million in Q1 2026, from $96.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $110.8 million in Q3 2025 to a low of $43.2 million in Q1 2022.
- A 5-year average of $72.3 million and a median of $70.0 million in 2023 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities jumped 122.26% in 2022 and fell 12.06% in 2025, its largest moves.
- Tracing INSP's Total Current Liabilities over 5 years: stood at $61.2 million in 2022, then increased by 27.65% to $78.1 million in 2023, then increased by 13.31% to $88.5 million in 2024, then gained by 8.54% to $96.1 million in 2025, then retreated by 6.91% to $89.4 million in 2026.
- Business Quant data shows INSP's Total Current Liabilities at $89.4 million in Q1 2026, $96.1 million in Q4 2025, and $110.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Inspire Medical Systems | 1.46 Bn | 1.17 Bn | 176.91 Mn | 89.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.42 Mn |
| Dec 31, 2025 | 96.06 Mn |
| Sep 30, 2025 | 110.84 Mn |
| Jun 30, 2025 | 93.36 Mn |
| Mar 31, 2025 | 63.47 Mn |
| Dec 31, 2024 | 88.50 Mn |
| Sep 30, 2024 | 74.26 Mn |
| Jun 30, 2024 | 65.66 Mn |
| Mar 31, 2024 | 72.17 Mn |
| Dec 31, 2023 | 78.11 Mn |
| Sep 30, 2023 | 70.00 Mn |
| Jun 30, 2023 | 66.69 Mn |
| Mar 31, 2023 | 59.87 Mn |
| Dec 31, 2022 | 61.19 Mn |
| Sep 30, 2022 | 49.29 Mn |
| Jun 30, 2022 | 46.85 Mn |
| Mar 31, 2022 | 43.17 Mn |
| Dec 31, 2021 | 41.31 Mn |
| Sep 30, 2021 | 33.59 Mn |
| Jun 30, 2021 | 24.35 Mn |